Hisun Pharma Signs Up GeneriCo to Market its Products in US

Zhejiang Hisun Pharma engaged GeneriCo, a specialty generic drug company based in Saint Louis, to be its sales and marketing partner in the US. Hisun has 20 generic drug applications pending with the US FDA. GeneriCo, a three-year old company, is developing several difficult-to-make generic drugs for US approval, but does not seem to be marketing any drugs at the moment. However, Tom Brya, President and CEO of GeneriCo, said the Hisun deal will allow GeneriCo to "extend and enhance" its commercialization programs. More details.... Stock Symbol: (SHA: 600267) Share this with colleagues: // //